{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:08:42Z","timestamp":1771589322256,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jtos.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T03:23:35Z","timestamp":1686194615000},"page":"314-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost"],"prefix":"10.1016","volume":"29","author":[{"given":"J.J.","family":"L\u00f3pez-Cano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Gonz\u00e1lez-Cela-Casamayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Andr\u00e9s-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vicario -de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Ben\u00edtez-del-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herrero-Vanrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.T.","family":"Molina-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2023.05.013_bib1","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jtos.2023.05.013_bib2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jtos.2023.05.013_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative effectiveness of first-line medications for primary open angle glaucoma \u2013 a systematic review and network meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2023.05.013_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: relative value and place in therapy of available drug treatments, Ther","volume":"5","author":"Sambhara","year":"2014","journal-title":"Adv. Chronic Dis"},{"key":"10.1016\/j.jtos.2023.05.013_bib5","first-page":"1967","article-title":"Latanoprost in the treatment of glaucoma","volume":"8","author":"Bazzaz","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.013_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.jtos.2023.05.013_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/tcrm.2006.2.2.193","article-title":"The management of glaucoma and intraocular hypertension: current approaches and recent advances","volume":"2","author":"Noecker","year":"2006","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.jtos.2023.05.013_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtos.2023.05.013_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/17425247.2021.1872542","article-title":"Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection","volume":"18","author":"L\u00f3pez-cano","year":"2021","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.jtos.2023.05.013_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajps.2013.07.013","article-title":"Preparation of bromfenac-loaded liposomes modified with chitosan for ophthalmic drug delivery and evaluation of physicochemical properties and drug release profile","volume":"8","author":"Tsukamoto","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1211\/0022357044896","article-title":"Development of a topical niosomal preparation of acetazolamide: preparation and evaluation","volume":"56","author":"Aggarwal","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jtos.2023.05.013_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1139\/cjc-2017-0193","article-title":"Dendrimers for ocular drug delivery","volume":"95","author":"Lancina","year":"2017","journal-title":"Can J Chem"},{"key":"10.1016\/j.jtos.2023.05.013_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib14","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/194848","article-title":"An overview on dry eye treatment: approaches for cyclosporin A delivery","author":"Yavuz","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.jtos.2023.05.013_bib15","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.xphs.2019.08.017","article-title":"AS1411 aptamer\/hyaluronic acid-bifunctionalized microemulsion Co-loading shikonin and docetaxel for enhanced antiglioma therapy","volume":"108","author":"Wang","year":"2019","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/10717544.2013.866992","article-title":"Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method","volume":"22","author":"Kotta","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2023.05.013_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4274\/tjps.galenos.2020.59319","article-title":"Nanoemulsions as ophthalmic drug delivery systems","volume":"18","author":"Dhahir","year":"2021","journal-title":"Turkish J Pharm Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib18","first-page":"1","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion","author":"Lallemand","year":"2012","journal-title":"Novasorb, J Drug Deliv"},{"key":"10.1016\/j.jtos.2023.05.013_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10091657","article-title":"Microemulsion microstructure(s): a tutorial review","volume":"10","author":"Tartaro","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtos.2023.05.013_bib21","first-page":"1","article-title":"Microemulsion: new insights into the ocular drug delivery","author":"Hegde","year":"2013","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2016.04.029","article-title":"Free amino acids: an innovative treatment for ocular surface disease","volume":"787","author":"Rusciano","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtos.2023.05.013_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5301\/EJO.2010.5730","article-title":"Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy","volume":"21","author":"Monaco","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.013_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2023.05.013_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exer.2016.04.019","article-title":"Clusterin in the eye: an old dog with new tricks at the ocular surface","volume":"147","author":"Fini","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5603\/OJ.2016.0024","article-title":"The impact of oleanolic and ursolic acid on corneal epithelial cells in vitro","volume":"1","author":"Matysik-Wo\u017aniak","year":"2017","journal-title":"Ophthalmol Times J"},{"key":"10.1016\/j.jtos.2023.05.013_bib27","doi-asserted-by":"crossref","first-page":"21813","DOI":"10.3390\/ijms160921813","article-title":"Surface properties of squalene\/meibum films and NMR confirmation of squalene in tears","volume":"16","author":"Ivanova","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-021-00228-4","article-title":"The effects of the molecular weights of hyaluronic acid on the immune responses","volume":"25","author":"Lee","year":"2021","journal-title":"Biomater Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ICO.0b013e3181b11648","article-title":"Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study","volume":"29","author":"Sanchez","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2023.05.013_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108723","article-title":"Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments","volume":"211","author":"L\u00f3pez-Cano","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/polym11060929","article-title":"Osmoprotectants in hybrid liposome\/HPMC systems as potential glaucoma treatment","volume":"11","author":"G\u00f3mez-Ballesteros","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.jtos.2023.05.013_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2022.121948","article-title":"Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection","volume":"623","author":"Lopez-Cano","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib33","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1213\/01.ANE.0000087802.50796.FB","article-title":"Physicochemical compatibility of propofol-lidocaine mixture","volume":"97","author":"Masaki","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtos.2023.05.013_bib34","article-title":"Bioanalytical method development and validation for latanoprost quantification in pharmaceutical opthalmic microemulsion formulation by RP-HPLC","volume":"6","author":"Patel","year":"2015","journal-title":"UNIMAID J Priv Prop Law"},{"key":"10.1016\/j.jtos.2023.05.013_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02713683.2017.1418893","article-title":"Measurement of the retention time of different ophthalmic formulations with ultrahigh-resolution optical coherence tomography","volume":"43","author":"Gagliano","year":"2018","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib37","series-title":"Guideline on the investigation of bioequivalence discussion","year":"2010"},{"key":"10.1016\/j.jtos.2023.05.013_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/03639045.2016.1238924","article-title":"Tear fluid-eye drops compatibility assessment using surface tension","volume":"43","author":"Hotujac Grgurevi\u0107","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/ICO.0000000000000368","article-title":"Osmolarity of prevalent eye drops, side effects, and therapeutic approaches","volume":"34","author":"Dutescu","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2023.05.013_bib40","first-page":"1","article-title":"Novel drug delivery systems fighting glaucoma: formulation obstacles and solutions","volume":"13","author":"Rahi\u0107","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2023.05.013_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/OPTH.S229815","article-title":"Impact of ocular surface disease treatment in patients with glaucoma","volume":"14","author":"Boso","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2023.05.013_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.05.013_bib43","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1080\/02713683.2021.1942071","article-title":"Phase transition microemulsion of brimonidine tartrate for glaucoma therapy: preparation, characterization and pharmacodynamic study","volume":"46","author":"Gautam","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib44","article-title":"Bimatoprost loaded microemulsion laden contact lens to treat glaucoma","volume":"54","author":"Xu","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2023.05.013_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2005.08.017","article-title":"Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol","volume":"305","author":"Sakai","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib46","volume":"vol. 23","author":"Labetoulle","year":"2022"},{"key":"10.1016\/j.jtos.2023.05.013_bib47","first-page":"3453","article-title":"Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis","volume":"9","author":"Shen","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2023.05.013_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/sca.4950240205","article-title":"Conditions for imaging emulsions in the environmental scanning electron microscope","volume":"24","author":"Mathews","year":"2002","journal-title":"Scanning"},{"key":"10.1016\/j.jtos.2023.05.013_bib49","series-title":"Extracell. Vesicles methods protoc. Methods mol. Biol.","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-7253-1_18","article-title":"Detection and characterization of extracellular vesicles by transmission and cryo-transmission electron microscopy","author":"Cizmar","year":"2017"},{"key":"10.1016\/j.jtos.2023.05.013_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2818.1989.tb00570.x","article-title":"An investigation of the fixation and staining of lipids by a combination of malachite green or other triphenylmethane dyes with glutaraldehyde","volume":"154","author":"Lawton","year":"1988","journal-title":"J Microsc"},{"key":"10.1016\/j.jtos.2023.05.013_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119402","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic\/pharmacodynamic properties","volume":"583","author":"Ismail","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2023.05.013_bib52","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J Biochem Pharmacol Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2016.06.014","article-title":"Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa","volume":"788","author":"Trzeciecka","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtos.2023.05.013_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2016.11.010","article-title":"Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: in vitro and ex vivo functionality studies in corneal epithelial cells","volume":"154","author":"Soriano-Roman\u00ed","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.05.013_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jmi.12179","article-title":"High resolution SEM imaging of gold nanoparticles in cells and tissues","volume":"256","author":"Goldstein","year":"2014","journal-title":"J Microsc"},{"key":"10.1016\/j.jtos.2023.05.013_bib56","series-title":"Microemulsion delivery system improves cellular uptake of genipin and its protective effect against A \u03b2 1-42-induced PC12 cell cytotoxicity","first-page":"1","author":"Zheng","year":"2022"},{"key":"10.1016\/j.jtos.2023.05.013_bib57","article-title":"Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells","volume":"16","author":"Carmona-Ule","year":"2020","journal-title":"Mater Today Chem"},{"key":"10.1016\/j.jtos.2023.05.013_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11745-002-0933-z","article-title":"Antihypertensive effects of a dietary unsaturated FA mixture in spontaneously hypertensive rats","volume":"37","author":"Bellenger-Germain","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.jtos.2023.05.013_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12019-w","article-title":"Lecithin derived from \u03c9-3 PUFA fortified eggs decreases blood pressure in spontaneously hypertensive rats","volume":"7","author":"Nowacki","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.05.013_bib60","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1085\/jgp.201812179","article-title":"TREK-1 channels regulate pressure sensitivity and calcium signaling in trabecular meshwork cells","volume":"150","author":"Yarishkin","year":"2018","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jtos.2023.05.013_bib61","first-page":"347","article-title":"Localization of smooth muscle myosin-containing cells in the aqueous outflow pathway","volume":"31","author":"De Kater","year":"1990","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib62","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1167\/iovs.11-9046","article-title":"Unoprostone isopropyl and metabolite M1 activate BK channels and prevent ET-1-induced [Ca2+]i increases in human trabecular meshwork and smooth muscle","volume":"53","author":"Cuppoletti","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.05.013_bib63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jop.2011.0245","article-title":"A comparative study of a preservative-free latanoprost cationic emulsion (catioprost) and a BAK-preserved latanoprost solution in animal models","volume":"28","author":"Daull","year":"2012","journal-title":"J Ocul Pharmacol Therapeut"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012423000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T23:23:26Z","timestamp":1716420206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012423000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":63,"alternative-id":["S1542012423000551"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2023.05.013","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}